Biotech Law 
Supreme Court upholds ACA, biotech threats disappear – FierceBiotech
With the mandate left in place and the law upheld, with the conservative John Roberts providing the swing vote, the Biotechnology Industry Organization and others can turn the page for now to other matters. “The Affordable Care Act’s requirement …
Biotech threats disappear as Supreme Court upholds health law – FierceBiotech
Biotech industry leaders breathed a sigh of relief this morning. The United States Supreme Court has narrowly upheld most of the Affordable Care Act, retaining a mandate that requires individuals to purchase insurance or face a penalty.
How Monsanto Is Sabotaging Efforts to Label Genetically Modified Food – AlterNet
Lobbyists from the biotech industry have ardently opposed GMO labelling … explained that states planning to vote on GM labelling in November could face a legal fight to defend their right to enact such laws. “However, this amendment would …
D-Day for Obamacare: Trading the Outcomes – CNBC
However, if the rest of the law stands, Mark Schoenebaum of ISI Group says a hidden impact could be a drag on earnings across biotech and pharma broadly, because the fees and dings in the legislation would remain in tact. … Continue reading
BIO Commends Senate for Approval of User Fee Package – Marketwatch
WASHINGTON, Jun 26, 2012 (BUSINESS WIRE) — Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement on passage of S. 3187, the Food and Drug Administration Safety and Innovation Act (FDASIA), by …
Modigene Inc. : Data From Phase II Trial of Prolor Biotech’s Long-acting Human Growth Hormone Presented at Endo 2012 – 4-traders (press release)
The forward-looking statements contained in this press release speak only as of the date the statements were made, and we do not undertake any obligation to update forward-looking statements, except as required under applicable law. 05/16 Prolor biotech …
BIO Commends Senate for Approval of User Fee Package FDASIA headed to President for signature into law – CNBC
WASHINGTON, Jun 26, 2012 (BUSINESS WIRE) — Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement on passage of S. 3187, the Food and Drug Administration Safety and Innovation Act (FDASIA), by the U.S …
BIO Commends Senate for Approval of User Fee Package – Business Wire
WASHINGTON–(BUSINESS WIRE)–Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement on passage of S. 3187, the Food and Drug Administration Safety and Innovation Act (FDASIA), by the U.S. Senate …
Sinovac Biotech Ltd. : Sinovac Reports Progress in EV71 Vaccine Phase III Clinical Trial and Commercialization Preparation Status – 4-traders (press release)
Sinovac Biotech Ltd. is a China-based biopharmaceutical company that … except as required under applicable law. 05/08 Sinovac to Host Conference Call to Report First Quarter … 05/08 Sinovac to Host Conference Call to Report First Quarter 2012 Unaudited …
Bioheart’s Chief Science Officer Kristin Comella Presents at 10th Annual Meeting of International Society for Stem Cell Research in Yokohama, Japan June 13-16, 2012 – msnbc.com
Specific to biotechnology, Bioheart is focused on the discovery … management’s beliefs and assumptions only as of the date hereof. Except as required by law, we assume no obligation to update these forward-looking statements publicly, or …
